Predictors and Long‐Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug‐Eluting Stents (ADAPT‐DES) Intravascular Ultrasound Substudy

Predictors and Long‐Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug‐Eluting Stents (ADAPT‐DES) Intravascular Ultrasound Substudy

BackgroundThe impact of acute stent malapposition (ASM) on long‐term clinical outcomes in patients undergoing percutaneous coronary intervention is still controversial. We sought to evaluate predictors and long‐term clinical outcomes of ASM. Methods and ResultsADAPT‐DES (Assessment of Dual Antiplate...

Full description

Bibliographic Details
Main Authors:	Bin Wang, Gary S. Mintz, Bernhard Witzenbichler, Cristiano F. Souza, D. Christopher Metzger, Michael J. Rinaldi, Peter L. Duffy, Giora Weisz, Thomas D. Stuckey, Bruce R. Brodie, Mitsuaki Matsumura, Myong‐Hwa Yamamoto, Rupa Parvataneni, Ajay J. Kirtane, Gregg W. Stone, Akiko Maehara
Format:	Article
Language:	English
Published:	Wiley 2016-12-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	coronary artery disease intravascular imaging malapposition stent
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.116.004438

Similar Items

Erosion/malapposition of a sirolimus eluting stent – Optical coherence tomography image – A case report
by: G. Sengottuvelu
Published: (2012-11-01)

Evaluation of post-dilatation on longitudinal stent deformation and postprocedural stent malapposition in the left main artery by optical coherence tomography (OCT): an in vitro study
by: Qing He, et al.
Published: (2024-03-01)

Computational simulation of stent thrombosis induced by various degrees of stent malapposition
by: Zhuoran Qu, et al.
Published: (2022-11-01)

Late presentation of recurrent syncope after permanent pacemaker implantation due to Lead−Header malapposition
by: Steven Mazzone, et al.
Published: (2021-03-01)

Impact of Malapposed and Overlapping Stents on Hemodynamics: A 2D Parametric Computational Fluid Dynamics Study
by: Manuel Lagache, et al.
Published: (2021-04-01)

Flow diverter tail malapposition after implantation in the internal carotid artery for aneurysm treatment: a preliminary study
by: Zheng Wan, et al.
Published: (2023-11-01)

The role of optical coherence tomography guidance in scaffold versus stent optimization
by: Arif A. Al Nooryani, et al.
Published: (2020-11-01)

Severe Acute Stent Malapposition After Drug‐Eluting Stent Implantation: Effects on Long‐Term Clinical Outcomes
by: Seung‐Yul Lee, et al.
Published: (2019-07-01)

Long‐Term Clinical Outcomes of Late Stent Malapposition Detected by Optical Coherence Tomography After Drug‐Eluting Stent Implantation
by: Eui Im, et al.
Published: (2019-04-01)

Vascular Response to Experimental Stent Malapposition and Under-Expansion
by: Bailey, Lynn, et al.
Published: (2017)

The “Oculo‐Appositional Reflex”: Should Optical Coherence Tomography–Detected Stent Malapposition Be Corrected?
by: Ziad A. Ali, et al.
Published: (2019-04-01)

Can antiplatelet therapy after drug eluting stent become a problem?
by: Michele Romano
Published: (2009-03-01)

Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy
by: Kush P. Patel, MBBS, et al.
Published: (2022-01-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
by: Thim Troels, et al.
Published: (2012-03-01)

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial
by: Zacharenia Kallinikou, et al.
Published: (2016-01-01)

Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy
by: Joanna Fluder-Wlodarczyk, et al.
Published: (2024-03-01)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
by: Mengjin Hu, et al.
Published: (2022-07-01)

Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second‐Generation Drug‐Eluting Stents
by: Choongki Kim, et al.
Published: (2020-06-01)

Different patterns of in-stent coverage in drug-eluting stents
by: Daniele Gemma, et al.
Published: (2017-11-01)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
by: Nisha Ohri, MD, et al.
Published: (2016-01-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
by: Michał Hawranek, et al.
Published: (2021-12-01)

Long-term outcomes following drug-eluting balloon or thin-strut drug-eluting stents for treatment of in-stent restenosis stratified by duration of dual antiplatelet therapy (DEB-Dragon Registry)
by: Rafał Januszek, et al.
Published: (2022-04-01)

Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010-09-01)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
by: Porto, I, et al.
Published: (2005)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
by: А. Н. Кудряшов, et al.
Published: (2017-04-01)

Comparing long-term antiplatelet strategies to prevent morbidity and mortality in patients with drug-eluting coronary stents
by: Evans, J. Stewart (James Stewart)
Published: (2011)

Pulmonary embolism in a patient in dual antiplatelet therapy after placement of a drug-eluting stent
by: Maria Cristina Vedovati
Published: (2018-11-01)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
by: Flavius-Alexandru Gherasie, et al.
Published: (2023-04-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents.
by: Matthijs A Velders, et al.
Published: (2014-01-01)

SECOND GENERATION DRUG-ELUTING STENT IMPLANTATION FOLLOWED BY SIX- VERSUS TWELVE-MONTH DUAL ANTIPLATELET THERAPY
Published: (2016-03-01)

Impact of medication adherence to dual antiplatelet therapy on the long-term outcome of drug-eluting or bare-metal stents.
by: Jung Min Choi, et al.
Published: (2020-01-01)

Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
by: Vassilis Voudris, et al.
Published: (2014-12-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01)

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
by: Alev Arat Ozkan, et al.
Published: (2016-05-01)

Everolimus-eluting stents in interventional cardiology
by: Townsend JC, et al.
Published: (2012-06-01)

Drug-eluting metallic stents in urology
by: Panagiotis S Kallidonis, et al.
Published: (2014-01-01)

Transradial Intravascular Ultrasound Guided Culotte Stenting with Zotarolimus Eluting Coronary Stents in Renal Artery Bifurcation Stenosis
by: Z. Ruzsa, et al.
Published: (2015-01-01)